![]() ![]() ![]() Changes in endogenous dopamine induced by methylphenidate predict functional connectivity in nonhuman primates. Long-term methylphenidate intake in chronic fatigue syndrome. Differential dopamine function in fibromyalgia. Iron, dopamine, genetics, and hormones in the pathophysiology of restless legs syndrome. Khan FH, Ahlberg CD, Chow CA, Shah DR, Koo BB. Dysfunctional striatal dopamine signaling in Huntington's disease. Investigational drugs for the treatment of binge eating disorder (BED): an update. The effect of atorvastatin on obsessive-compulsive symptoms of refractory obsessive-compulsive disorder (add-on therapy). ![]() Psychopharmacology of attention-deficit hyperactivity disorder: effects and side effects. Golmirzaei J, Mahboobi H, Yazdanparast M, Mushtaq G, Kamal MA, Hamzei E. ADHD risk genes involved in dopamine signaling and metabolism are associated with reduced estimated life expectancy at young adult follow-up in hyperactive and control children. Dysregulation of the dopamine system in the pathophysiology of schizophrenia and depression. Abnormal concentration of GABA and glutamate in the prefrontal cortex in schizophrenia.-An in vivo 1h-mrs study. Excessive social media users demonstrate impaired decision making in the Iowa Gambling Task. Meshi D, Elizarova A, Bender A, Verdejo-Garcia A. Fibrofog and fibromyalgia: a narrative review and implications for clinical practice. Impaired fine motor function of the asymptomatic hand in unilateral Parkinson’s disease. Parkinson's disease.ĭan X, Liu J, Doyon J, Zhou Y, Ma J, Chan P. National Institutes of Health, National Institute on Aging. Dopamine transporter and reward anticipation in a dimensional perspective: a multimodal brain imaging study. The role of dopamine and its dysfunction as a consequence of oxidative stress. Juárez Olguín H, Calderón Guzmán D, Hernández García E, Barragán Mejía G. The dopamine hypothesis of bipolar affective disorder: the state of the art and implications for treatment. G protein-coupled receptor kinases as regulators of dopamine receptor functions. Gurevich EV, Gainetdinov RR, Gurevich VV. Impaired dopamine metabolism in Parkinson's disease pathogenesis. Masato A, Plotegher N, Boassa D, Bubacco L. The role of dopamine in schizophrenia from a neurobiological and evolutionary perspective: old fashioned, but still in vogue. Brain reward pathways.īrisch R, Saniotis A, Wolf R, et al. The brain's reward system in health and disease. ![]()
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |